Download PDFPDF

B type natriuretic peptide testing: where are we now?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Reproductability of N-terminal BNP in stable patients with systelic heart failure
    • Manuel Jiménez-Navarro MD
    • Other Contributors:
      • Maria Fernández-Moyano MD, Antonio Domínguez-Franco MD, Juan José Gómez-Doblas MD, Encarnación Molero MD, Eduardo de Teresa MD, FESC

    Dear Editor

    We have read with great interest the recent editorial about B type natriuretic peptide (BNP) by MR Cowie [1].

    Treatment monitoring could be an especially interesting role of this peptide. We report our experience about the reproducibility of N terminal proBNP (NT-proBNP) in patients with stable chronic symptomatic heart failure of any aetiology with systolic heart failure.

    We recruited 34...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    BNP testing - jumping the gun

    Dear Editor

    The current evidence does not support the recommendation of Prof. Cowie [1]. and NICE [2]. that BNP testing is an acceptable method to rule out heart failure. Cowie takes an even more restrictive view than the NICE guidance and suggests limiting BNP testing to newly presenting patients not yet on treatment, whilst NICE makes no such distinction. Even in this more restricted setting, the New Zealand t...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Is it cost effective?

    Dear Editor

    As mentioned in the editorial, BNP has a very good negative predictive value. This was noted in the North Glasgow study. So patients who present with acute breathing difficulties and have a negative BNP are very unlikely to have ventricular dysfunction.

    Other diagnosis would have to be considered but will this prevent us from performing echocardiograms on this set of patients to definitely ru...

    Show More
    Conflict of Interest:
    None declared.